#USA #Inc. #financial results #Astrana Health #Alhambra #Q3 2026

Astrana Health, Inc. Reports Exceptional Third Quarter 2026 Results

Astrana Health, Inc. has recently announced its financial results for the third quarter ending September 30, 2026, reporting a record total revenue of $1,023.6 million, reflecting a 7% increase from the previous year. This rise demonstrates the effectiveness of the company's ongoing strategies and its commitment to providing high-quality healthcare.

CEO Brandon Sim remarked on the results, stating, "Our third quarter outcomes signify the growing influence of Astrana’s healthcare platform, which is primarily focused on integrating AI and enhancing physician partnerships to elevate patient care. Our commitment is evident in our consistent growth in revenue, and we are proud of the double-digit organic earnings growth we achieved this quarter."

Financial Highlights

Some of the critical financial statistics for Q3 2026 include:

• - Net income reached $20.3 million, representing an astounding increase of 1,782% compared to the previous year’s quarter.
• - Adjusted EBITDA was reported at $77.2 million, marking a 13% increase from the previous year’s results.
• - The earnings per diluted share escalated to $0.26 from $0.01.

For the nine-month period ending September 30, 2026, total revenue surged to $2,961.2 million, up 33% from $2,231.2 million in the same period last year. The net income for this period also saw a remarkable 186% increase, totaling $47.1 million, alongside a diluted earnings per share jump to $0.95.

Operational Highlights

Astrana Health's performance during this quarter can be attributed to several operational achievements:

• - The company completed the acquisition of an independent practice association in Georgia on October 1.
• - Two new Care Enablement clients were welcomed: a provider group in Connecticut and a hospital in California, both expected to integrate Astrana's cutting-edge AI technology and managed services in early 2027.
• - The establishment of new partnerships within the Medicare Advantage segment aims to fortify membership growth across diverse markets including Southern California, Texas, and Arizona.

Moving Forward

Looking ahead, Astrana has provided guidance for Q4 2026, projecting total revenue between $939 million and $1,039 million and adjusted EBITDA of $48.5 million to $61.5 million. These optimistic projections emphasize the company’s strategic focus on sustainable growth and innovation within the healthcare sector.

As the company gears up for future success, it will be hosting a conference call on November 5, 2026, at 2:30 PM PT/5:30 PM ET, where management will detail the Q3 results and address future guidance. Investors and stakeholders are encouraged to participate by accessing the dedicated conference call numbers provided.

Astrana Health continues to thrive as a physician-centric, technology-driven healthcare company that is redefining patient care and outcomes, making strides toward delivering more accessible and high-value healthcare services. With over 20,000 providers and 1.5 million patients benefiting from value-based care arrangements, Astrana is setting new benchmarks in the healthcare landscape.

For more information, visit Astrana Health's website.